NEKTAR THERAPEUTICS (NKTR) › RevenueNEKTAR THERAPEUTICS (NKTR) — RevenueAnnual figures by period end, from SEC filings.2016-12-31: $165.44M2017-12-31: $307.71M2018-12-31: $1.19B2019-12-31: $114.62M2020-12-31: $152.91M2021-12-31: $101.91M2022-12-31: $92.06M2023-12-31: $90.12M2024-12-31: $98.43M2025-12-31: $55.23M$55.23M2016-12-31Revenue (USD)2025-12-31Period endedRevenueChange YoYSource filing2025-12-31$55.23M-43.9%2026-03-13From 2025-01-012024-12-31$98.43M+9.2%2026-03-13From 2024-01-012023-12-31$90.12M-2.1%2025-03-14From 2023-01-012022-12-31$92.06M-9.7%2024-03-05From 2022-01-012021-12-31$101.91M-33.4%2024-03-05From 2021-01-012020-12-31$152.91M+33.4%2023-02-28From 2020-01-012019-12-31$114.62M-90.4%2022-03-01From 2019-01-012018-12-31$1.19B+287.8%2021-02-26From 2018-01-012017-12-31$307.71M+86.0%2020-02-28From 2017-01-012016-12-31$165.44M—2019-03-01From 2016-01-01Other metrics: Cost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per ShareWeighted Average Diluted SharesEPS (Basic)